A study comparing 20% albumin with crystalloids in the treatment of critical phase of dengue fever in children between the ages of 1 and 12 years
Phase 1
- Conditions
- Health Condition 1: B349- Viral infection, unspecified
- Registration Number
- CTRI/2023/06/053816
- Lead Sponsor
- Dr Pavandev
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Microbiologically proven Dengue Fever
Exclusion Criteria
Age less than 1 year and age more than 12 years
Patients who are in recovery phase
Patients having known allergy to inj albumin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of 20% albumin vs Crystalloid infusion as a treatment modality in critical phase of Dengue FeverTimepoint: baseline assessment of blood pressure, hematocrit levels, urine output,serial complete blood hemogram at 2hrs,4hrs,8hrs,12hrs,18hrs,24hrs, 48hrs, 72 hrs
- Secondary Outcome Measures
Name Time Method To compare the length of stay in PICU & early recovery <br/ ><br>To study the effect on mortality <br/ ><br>To study the side effects of albuminTimepoint: Assesment of overall recovery & prognosis at the end of 4 days, 7 days , 10 days & 14 days